COPD/asthma related pneumonia or pneumonia derived septichaemia

No definition available.

Endpoint definition

FinnGen phenotype data

Filter registries None

Check pre-conditions None

diagram bullet diagram downward connector

Include endpoints

Check conditions None

Apply sex-specific rule None

diagram downward connector COPD_ASTHMA_PNEUMONIA_SEPSIS

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to COPD/asthma related pneumonia or pneumonia derived septichaemia based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 34103 15092 19011
Unadjusted prevalence (%) 13.11 10.27 16.81
Mean age at first event (years) 54.33 51.52 56.57

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.12 9.24 [8.40, 10.16] <1e-100 9169
15 years 0.08 10.88 [10.01, 11.83] <1e-100 8749
5 years 0.03 20.67 [19.05, 22.42] <1e-100 6752
1 year 0.01 53.80 [47.35, 61.13] <1e-100 4234

Correlations

Index endpoint: COPD_ASTHMA_PNEUMONIA_SEPSIS – COPD/asthma related pneumonia or pneumonia derived septichaemia
GWS hits: 2

Survival analyses between endpoints

Plot

before COPD/asthma related pneumonia or pneumonia derived septichaemia
after COPD/asthma related pneumonia or pneumonia derived septichaemia

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after COPD/asthma related pneumonia or pneumonia derived septichaemia